Daniel W Pita-Thomas1, Jeffrey L Goldberg. 1. Bascom Palmer Eye Institute, Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Abstract
PURPOSE OF REVIEW: Current medical treatments designed to halt the progressive loss of retinal ganglion cells (RGCs) in glaucoma are limited by low bioavailability to target tissues and lack of patient adherence to frequent dosing regimens. For a certain percentage of patients with glaucoma, reducing intraocular pressure (IOP) does not stop disease progression, motivating the search for new therapeutic targets and delivery systems. RECENT FINDINGS: The emerging science of nanoparticles has the potential to address the current limitations of glaucoma therapy by improving drug bioavailability, exploiting IOP-independent targets such as RGC neuroprotection, and optimizing gene therapy as a more permanent treatment for glaucoma. SUMMARY: We review the recent advances in nanoparticle-based glaucoma therapy with a focus on drug delivery to the eye, as well as novel applications including gene therapy.
PURPOSE OF REVIEW: Current medical treatments designed to halt the progressive loss of retinal ganglion cells (RGCs) in glaucoma are limited by low bioavailability to target tissues and lack of patient adherence to frequent dosing regimens. For a certain percentage of patients with glaucoma, reducing intraocular pressure (IOP) does not stop disease progression, motivating the search for new therapeutic targets and delivery systems. RECENT FINDINGS: The emerging science of nanoparticles has the potential to address the current limitations of glaucoma therapy by improving drug bioavailability, exploiting IOP-independent targets such as RGC neuroprotection, and optimizing gene therapy as a more permanent treatment for glaucoma. SUMMARY: We review the recent advances in nanoparticle-based glaucoma therapy with a focus on drug delivery to the eye, as well as novel applications including gene therapy.
Authors: Lei Zhao; Guojun Chen; Jun Li; Yingmei Fu; Timur A Mavlyutov; Annie Yao; Robert W Nickells; Shaoqin Gong; Lian-Wang Guo Journal: J Control Release Date: 2017-01-04 Impact factor: 9.776
Authors: Stavros N Moysidis; Karen Alvarez-Delfin; Veronica J Peschansky; Enrique Salero; Alejandra D Weisman; Alena Bartakova; Gabriella A Raffa; Richard M Merkhofer; Karl E Kador; Noelia J Kunzevitzky; Jeffrey L Goldberg Journal: Nanomedicine Date: 2015-01-14 Impact factor: 5.307
Authors: Wolfgang Pita-Thomas; Michael B Steketee; Stavros N Moysidis; Kinjal Thakor; Blake Hampton; Jeffrey L Goldberg Journal: Nanomedicine Date: 2015-01-14 Impact factor: 5.307
Authors: Andrea E Dillinger; Michaela Guter; Franziska Froemel; Gregor R Weber; Kristin Perkumas; W Daniel Stamer; Andreas Ohlmann; Rudolf Fuchshofer; Miriam Breunig Journal: Small Date: 2018-10-23 Impact factor: 13.281
Authors: Wendi S Lambert; Brian J Carlson; Alice E van der Ende; Grace Shih; Julia N Dobish; David J Calkins; Eva Harth Journal: Transl Vis Sci Technol Date: 2015-01-13 Impact factor: 3.283
Authors: Raphael Mietzner; Christian Kade; Franziska Froemel; Diana Pauly; W Daniel Stamer; Andreas Ohlmann; Joachim Wegener; Rudolf Fuchshofer; Miriam Breunig Journal: Pharmaceutics Date: 2020-07-27 Impact factor: 6.321